LAHHP Hackney 2023-12-15

Local authority health protection profile

Hackney

Field Service, Regions Directorate, Health Protection Operations

15 December 2023

 

Warning: The data in this report either refers to Hackney or both Hackney and City of London combined. Unfortunately it has not been possible in this automated report to highlight which of these options applies for each data item. However, information on this is available on the online SRH profiles https://fingertips.phe.org.uk/profile/sexualhealth.

Summary

The following indicators are better in Hackney than in England:

  • Campylobacter incidence rate/100,000 (2017)
  • Giardia incidence rate/100,000 (2017)
  • Cryptosporidium incidence rate/100,000 (2017)
  • Chlamydia proportion aged 15 to 24 screened (2022)
  • STI testing rate (exclude chlamydia aged under 25) per 100,000 (2022)
  • HIV testing coverage, total (2022)
  • HIV testing coverage, men (2022)
  • HIV testing coverage, women (2022)
  • HIV testing coverage, gay, bisexual and other men who have sex with men (2022)
  • Repeat HIV testing in gay, bisexual and other men who have sex with men (2022)
  • Scarlet fever notification rate/100,000 aged 0-9 yrs (2021)
  • Adjusted antibiotic prescribing in primary care by the NHS (2022)
  • Chlamydia detection rate per 100,000 aged 15 to 24 (Male) (2022)
  • Chlamydia detection rate per 100,000 aged 15 to 24 (Persons) (2022)

The following indicators are worse in Hackney than in England:

  • Non-typhoidal Salmonella incidence rate/100,000 (2017)
  • Shigella incidence rate/100,000 (2017)
  • Measles 5-year incidence rate/100,000 (2017 - 21)
  • Children in care immunisations (2022)
  • Population vaccination coverage: Rotavirus (Rota) (1 year) (2022/23)
  • Population vaccination coverage: Dtap IPV Hib (1 year old) (2022/23)
  • Population vaccination coverage: Hib and MenC booster (2 years old) (2022/23)
  • Population vaccination coverage: MMR for one dose (2 years old) (2022/23)
  • Population vaccination coverage: Dtap IPV Hib (2 years old) (2022/23)
  • Population vaccination coverage: PCV booster (2022/23)
  • Population vaccination coverage - Hib / Men C booster (5 years old) (2017/18)
  • Population vaccination coverage: MMR for one dose (5 years old) (2022/23)
  • Population vaccination coverage: MMR for two doses (5 years old) (2022/23)
  • Population vaccination coverage: Flu (primary school aged children) (2022)
  • Population vaccination coverage: Flu (at risk individuals) (2022/23)
  • Population vaccination coverage: Flu (aged 65 and over) (2022/23)
  • Population vaccination coverage: PPV (2020/21)
  • Population vaccination coverage: Meningococcal ACWY conjugate vaccine (MenACWY) (14 to 15 years) (2021/22)
  • Population vaccination coverage: Shingles vaccination coverage (71 years) (2021/22)
  • TB incidence (three year average) (2019 - 21)
  • Proportion of drug sensitive TB cases who were lost to follow up at last reported outcome (2019)
  • Persons entering drug misuse treatment - Percentage of eligible persons completing a course of hepatitis B vaccination (2016/17)
  • New STI diagnoses (excluding chlamydia aged under 25) per 100,000 (2022)
  • Chlamydia diagnostic rate per 100,000 aged 25 years and older (2022)
  • Gonorrhoea diagnostic rate per 100,000 (2022)
  • Syphilis diagnostic rate per 100,000 (2022)
  • Genital warts diagnostic rate per 100,000 (2022)
  • Genital herpes diagnosis rate per 100,000 (2022)
  • New HIV diagnosis rate per 100,000 (2022)
  • New HIV diagnoses among persons first diagnosed in the UK rate per 100,000 (2022)
  • HIV diagnosed prevalence rate per 1,000 aged 15 to 59 (2022)
  • Virological success in adults accessing HIV care (2022)
  • Population vaccination coverage: HPV vaccination coverage for two doses (13 to 14 years old)(Male) (2021/22)
  • Population vaccination coverage: HPV vaccination coverage for two doses (13 to 14 years old)(Female) (2021/22)

The following indicators are higher in Hackney than in England:

  • Hepatitis C detection rate/100,000 (2017)
  • All new STI diagnoses rate per 100,000 (2022)
  • Chlamydia diagnostic rate per 100,000 (2022)
  • Mycoplasma genitalium diagnostic rate per 100,000 (2022)
  • Trichomoniasis diagnostic rate per 100,000 (2022)
  • STI testing positivity (excluding chlamydia aged under 25) (2022)

Figure 1. Chart showing key health protection information for Hackney local authority residents compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Figure 2. Population vaccine coverage in Hackney compared to London region and England

Figure 3. Rates of selected indicators over time in Hackney compared to London region and England

Introduction

This report presents information on a range of health protection issues in a local area in an integrated way. This is produced alongside other UKHSA health intelligence tools to help local stakeholders identify health protection priorities.

This report is compiled from publically available data on the online Health Protection Profiles. Please access this tool for further data analysis and more information about the data which is described in the ‘definitions’ tab for each indicator. A list of data sources is available in the ‘Data sources’ section of this report.

It is important to understand the limitations of the data presented when interpreting a local authority indicator being higher/lower or better/worse than England. The caveats to each indicator are explained in the ‘definitions’ tab for each indicator on the online Health Protection Profiles. Interpretation of local variation will need consideration of a range of factors which may include:

  • variation in testing

  • variation in reporting

  • variation in the completeness of residence information. Cases may be assigned incorrectly to a local authority if postcode information is missing. In these circumstances the GP or laboratory postcode may be used instead

  • local outbreaks

The information in this report may differ from that originating from different data sources which are defined, collected, analysed in different ways. For example, information presented here may differ from that used locally which is sourced from HPZone, a UKHSA public health management system used by local Health Protection Teams.

City of London and Isles of Scilly are not included in the rankings in this document. Where comparisons are made to Hackney or Cornwall, please note that the data for these areas may have been combined with City of London and Isles of Scilly respectively. Please check the online Health Protection Profiles for this information.

This report has been developed for the best viewing experience in Google Chrome. It has also been tested with Microsoft Edge, but some content may look different. When viewed in Google Chrome, this report can be converted to a PDF through the Print menu. Select “Save as PDF” as the destination. For the best result, it is recommended to select the “background graphics” option and deselect the “headers and footers” option. Some other browsers also offer PDF conversion, but the formatting may not display as intended.

Gastrointestinal infections

This section has information on a range of gastrointestinal infections that are the focus of public health activity.

Figure 4. Chart showing gastrointestinal infections in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Table 1. Number of new cases of gastrointestinal infections by year, Hackney

Indicator 2012 2013 2014 2015 2016 2017 2018 2019
Typhoid/paratyphoid 1 5 6 6 6 3 3 4
Salmonella (non-typhoidal) - - - 37 43 59 - -
Campylobacter - - - 165 145 70 - -
Shigella - - - 84 64 62 - -
STEC O157 8 3 7 3 1 2 5 -
Listeria 2 2 1 2 3 0 0 -
Giardia - - - 6 6 2 - -
Cryptosporidium - - - 3 12 7 - -

Typhoid and paratyphoid

Typhoid and paratyphoid (also known as enteric fever) are diseases caused by Salmonella enterica serovar Typhi (typhoid) or Paratyphi A, B and C (paratyphoid). Classic typhoid fever is a serious disease which can be life-threatening unless treated promptly with antibiotics. Paratyphoid is typically milder than typhoid and of shorter duration. Typhoid and paratyphoid are almost exclusively acquired abroad through the ingestion of heavily contaminated food and water. Typhoid and paratyphoid are spread from person-to-person by the faecal-oral route. Therefore, their prevention and control is dependent on good sanitation, clean water and scrupulous personal hygiene. The typhoid vaccine offers limited protection against typhoid and no protection at all against paratyphoid. Variation in rates of typhoid and paratyphoid may reflect variation in underlying populations e.g. by ethnicity, but are also indicative of the need for a public health focus on pre-travel advice and vaccination.

In 2019, the number of Hackney residents who were diagnosed with typhoid or paratyphoid was 4 (the number in 2018 was 3). The typhoid/paratyphoid rate per 100,000 residents was 1.4 in 2019, similar to 0.7 per 100,000 in England. The rank of Hackney for this was 36th highest (out of 150 upper tier local authorities and unitary authorities (UTLAs/UAs)).

Figure 5. Rates per 100,000 population of typhoid/paratyphoid in 16 similar UTLAs/UAs and the London region, compared to England: 2019

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 6. Typhoid and paratyphoid diagnoses per 100,000 population in Hackney, the London region and England

Salmonella (non-typhoidal)

Salmonella is a bacteria that lives in the guts of domestic and wild animals including poultry, cattle, pigs, hedgehogs, snakes and lizards. Salmonella infection can cause gastrointestinal illness and in rare cases lead to complications such as sepsis. This section relates to the Salmonella causing food poisoning i.e. non-typhoidal Salmonella (not those causing typhoid or paratyphoid fever).

In 2017, the number of Hackney residents who were diagnosed with Salmonella was 59 (the number in 2016 was 43). The Salmonella diagnoses rate per 100,000 residents was 20.9 in 2017, worse than 15.7 per 100,000 in England. The rank of Hackney was 21st highest (out of 147 UTLAs/UAs). Since 2016, the increase in the rate of Salmonella in Hackney was 37%.

Figure 7. Rates per 100,000 population of Salmonella in 16 similar UTLAs/UAs and the London region, compared to England: 2017

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 8. Salmonella diagnoses per 100,000 population in Hackney, the London region and England

Campylobacter

Campylobacter causes food poisoning and is the most commonly reported bacterial gastrointestinal pathogen in England. The majority of infections result in self-limiting diarrhoea, however, infection has also been associated with chronic sequelae such as Guillain-Barré syndrome. Campylobacter causes a substantial community and healthcare burden in the UK. The bacteria lives in the gastrointestinal tract of a wide range of livestock (especially poultry) and wildlife species and in pets such as dogs and cats. People can get Campylobacter from raw or undercooked meat, especially chicken meat, unpasteurised milk or untreated water. Bacteria can spread easily through poor hygiene in food preparation, for example if you do not wash your hands, you can spread bacteria from chicken to salads.

In 2017, the number of Hackney residents who were diagnosed with Campylobacter was 70 (the number in 2016 was 145). The Campylobacter diagnoses rate per 100,000 residents was 24.7 in 2017, better than 96.6 per 100,000 in England. The rank of Hackney for this was 144th highest (out of 146 UTLAs/UAs). Since 2016, the decrease in Hackney was 52%.

Figure 9. Rates per 100,000 population of Campylobacter in 16 similar UTLAs/UAs and the London region, compared to England: 2017

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 10. Campylobacter diagnoses per 100,000 population in Hackney, the London region and England

STEC O157

Shiga toxin-producing Escherichia coli serogroup O157 (STEC) is a zoonotic gastrointestinal infection for which animals (particularly ruminants such as cattle and sheep) are the main reservoir. Transmission occurs either due to direct contact with infected animal faeces, ingestion of food contaminated with infected animal or human faeces or via contact with the infected faeces of another person. STEC causes moderate to severe disease in humans. Most cases will present with mild (diarrhoea) to moderate (bloody diarrhoea) gastrointestinal symptoms but a proportion (~ 5%) will go on to develop more severe complications such as haemolytic uraemic syndrome (HUS). Some complications may require long-term care or result in permanent disability (e.g. kidney failure). Infants, young children and the elderly are particularly vulnerable to such complications.

In 2018, the number of Hackney residents who were diagnosed with STEC O157 was 5 (the number in 2017 was 2). The 5 year mean STEC O157 diagnoses rate per 100,000 residents was 1.3 in 2014 - 18, similar to 1.2 per 100,000 in England. The rank of Hackney for this was 52nd highest (out of 148 UTLAs/UAs).

Figure 11. 5 year mean rates per 100,000 population of STEC O157 in 16 similar UTLAs/UAs and the London region, compared to England: 2014 - 18

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 12. STEC O157 diagnoses per 100,000 population in Hackney, the London region and England

Listeria

Listeria monocytogenes causes listeriosis, a rare but potentially life-threatening disease. Healthy adults are unlikely to experience infection, however, Listeria infection (listeriosis) is dangerous to pregnant women, the elderly and people with weakened immune systems. Listeria is typically spread by contaminated foods. Listeria is an unusual bacterium because it can grow at low temperatures, including refrigeration temperatures of below 5 degrees. It is, however, killed by cooking food thoroughly and by pasteurisation. Local variation in numbers may reflect poor food management, variation in the numbers of people with weakened immune systems or different uptake of food safety messages in pregnant women. Areas with persistent significantly high rates in the absence of known outbreaks should investigate the cause and should enhance prevention advice as appropriate.

In 2018, the number of Hackney residents who were diagnosed with Listeria was 0 (the number in 2017 was 0). The 5 year mean Listeria diagnoses rate per 100,000 residents was 0.4 in 2014 - 18, similar to 0.3 per 100,000 in England. The 5 year rank of Hackney was 28th highest (out of 148 UTLAs/UAs).

Figure 13. 5 year mean rates per 100,000 population of Listeria in 16 similar UTLAs/UAs and the London region, compared to England: 2014 - 18

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 14. Listeria diagnoses per 100,000 population in Hackney, the London region and England

Shigella

Shigellosis, also known as bacillary dysentery, is caused by four species. Shigella flexneri and Shigella sonnei are endemic in the UK while infections with Shigella dysenteriae and Shigella boydii are usually imported. Shigella generally causes a relatively mild illness, however 1 in 5 cases may progress to more severe disease, including hospitalisation due to bloody diarrhoea, persistent gastroenteritis or more severe complications such as bacteraemia. Patients with Shigella dysenteriae can also develop a very severe condition known as haemolytic uremic syndrome (HUS). Infection is readily transmitted from person to person, via the oro faecal route. In the past, shigellosis has primarily been associated with travel to countries with poor sanitation or transmission between young children and their care-givers in household, nursery or school settings. More recently, outbreaks of Shigella sonnei and Shigella flexneri have been linked to person-to-person spread among gay, bisexual and other men who have sex with men (GBMSM).

In 2017, the number of Hackney residents who were diagnosed with Shigella was 62 (the number in 2016 was 64). The Shigella diagnoses rate per 100,000 residents was 21.9 in 2017, worse than 3.5 per 100,000 in England. The rank of Hackney was 4th highest (out of 147 UTLAs/UAs).

Figure 15. Rates per 100,000 population of Shigella in 16 similar UTLAs/UAs and the London region, compared to England: 2017

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 16. Shigella diagnoses per 100,000 population in Hackney, the London region and England

Giardia

Giardia can be transmitted by direct contact with infected animals or humans, or by consumption of water, food or drinks contaminated by the faeces of infected animals or humans. People may also be infected by swimming in contaminated water e.g. lakes or rivers. Many cases are associated with foreign travel. Persistently significantly high rates of Giardia in the absence of known outbreaks would indicate the need to investigate the underlying reasons and reinforce prevention activity as appropriate e.g. advice regarding contact with animals.

In 2017, the number of Hackney residents who were diagnosed with Giardia was 2 (the number in 2016 was 6). The Giardia diagnoses rate per 100,000 residents was 0.7 in 2017, better than 8.5 per 100,000 in England. The rank of Hackney was 129th highest (out of 147 UTLAs/UAs). Since 2016, the decrease in the rate of Giardia in Hackney was 67%.

Figure 17. Rates per 100,000 population of Giardia in 16 similar UTLAs/UAs and the London region, compared to England: 2017

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 18. Giardia diagnoses per 100,000 population in Hackney, the London region and England

Crytposporidium

Cryptosporidiosis is a disease usually caused by the parasites Cryptosporidium hominis and C. parvum. It is most commonly seen in children aged between 1 and 5 years. People with weak immune systems are likely to be more seriously affected. The most common symptom is mild to severe watery diarrhoea. The parasites are resistant to chlorine. Outbreaks of cryptosporidiosis have been linked to drinking or swimming in contaminated water and contact with infected lambs and calves during visits to open farms. Persistently significantly high rates of Cryptosporidium in the absence of known outbreaks would indicate the need to investigate the underlying reasons and reinforce prevention activity as appropriate e.g. advice regarding contact with animals.

In 2017, the number of Hackney residents who were diagnosed with Cryptosporidium was 7 (the number in 2016 was 12). The Cryptosporidium diagnoses rate per 100,000 residents was 2.5 in 2017, better than 7.3 per 100,000 in England. The rank of Hackney was 114th highest (out of 147 UTLAs/UAs). Since 2016, the decrease in the rate of Cryptosporidium in Hackney was 42%.

Figure 19. Rates per 100,000 population of Cryptosporidium in 16 similar UTLAs/UAs and the London region, compared to England: 2017

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 20. Cryptosporidium diagnoses per 100,000 population in Hackney, the London region and England

Selected vaccine preventable diseases and immunisation

In this section we have included information about measles, mumps and pertussis. Information on rubella and polio is not yet available on the Health Protection Profiles. Information on hepatitis B is in the hepatitis section. Variation in the rates of infections may reflect differences in the underlying population, including variation in the uptake of vaccination. High rates should prompt a review of routine immunisation uptake and vaccination of high risk groups.

Figure 21. Chart showing childhood vaccine preventable diseases in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Meningococcal disease

Invasive meningococcal disease (IMD), caused by the bacteria Neisseria meningitidis, is an important cause of severe illness and death. Incidence is highest in children under five years of age, with a secondary peak in young people aged 15 to 19 years of age. Vaccination against the most common meningococcal groups are offered to children and adolescents as part of the UK immunisation schedule. High rates of invasive meningococcal disease should prompt review of the causes, for example, an outbreak or poor uptake of vaccination among risk groups.

In the period Jul 2020 - Jun 2021, the number of Hackney residents who were diagnosed with confirmed invasive meningococcal disease was 0. The invasive meningococcal disease diagnoses rate per 100,000 residents was 0.0 in Jul 2020 - Jun 2021, similar to 0.1 per 100,000 in England. The rank of Hackney for this was 114th highest (out of 150 UTLAs/UAs).

Figure 22. Rates per 100,000 population of confirmed invasive meningococcal disease in 16 similar UTLAs/UAs and the London region, compared to England: Jul 2020 - Jun 2021

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Measles

Measles is the most infectious of all diseases transmitted through the respiratory route. It can lead to severe complications, particularly in immunosuppressed individuals and young infants. Measles infection during pregnancy increases the risk of miscarriage, stillbirth or preterm delivery. The most effective way to control measles is by achieving high uptake of two doses of measles, mumps, rubella (MMR) vaccine.

In 2021, the number of Hackney residents who were diagnosed with measles was 0 (the number in 2020 was 0). The 5 year mean measles diagnoses rate per 100,000 residents was 11.5 in 2017 - 21, worse than 0.8 per 100,000 in England. The rank of Hackney for this was highest (out of 150 UTLAs/UAs).

Figure 23. 5 year rates per 100,000 population of measles in 16 similar UTLAs/UAs and the London region, compared to England: 2017 - 21

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 24. Measles diagnoses per 100,000 population in Hackney, the London region and England

Mumps

Mumps is a vaccine preventable viral infection which can occasionally cause severe complications, including swelling of the ovaries (oophoritis), swelling of the testes (orchitis), aspetic meningitis and deafness.

In 2018, the number of Hackney residents who were diagnosed with mumps was 5 (the number in 2017 was 12). Since 2017, the decrease in the rate of mumps in Hackney was 59%. The 5 year mean mumps diagnoses rate per 100,000 residents was 2.7 in 2012 - 16, similar to 3.6 per 100,000 in England. The rank of Hackney for this was 70th highest (out of 150 UTLAs/UAs).

Figure 25. 5 year rates per 100,000 population of mumps in 16 similar UTLAs/UAs and the London region, compared to England: 2012 - 16

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 26. Mumps diagnoses per 100,000 population in Hackney, the London region and England

Pertussis

Pertussis (whooping cough) is a vaccine preventable bacterial infection and causes a prolonged cough illness, with the majority of cases occurring in individuals aged 15 years and over. However, it result in life threatening complications in infants under 6 months of age and immunosuppressed individuals.

In 2021, the number of Hackney residents who were diagnosed with pertussis was 0 (the number in 2020 was 7). The pertussis diagnoses rate per 100,000 residents was 0.0 in 2021, similar to 0.1 per 100,000 in England. The rank of Hackney for this was 103rd highest (out of 150 UTLAs/UAs).

Figure 27. Rates per 100,000 population of pertussis in 16 similar UTLAs/UAs and the London region, compared to England: 2021

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 28. Pertussis diagnoses per 100,000 population in Hackney, the London region and England

Immunisation

The World Health Organization (WHO) says that the 2 public health interventions that have had the greatest impact on the world's health are clean water and vaccines. ‘Immunisation against infectious disease’, also known as the Green Book, has the latest information on vaccines and vaccination procedures in the UK. Vaccination coverage is the best indicator of the level of protection a population will have against vaccine preventable communicable diseases. Coverage is closely correlated with levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise. Previous evidence shows that highlighting vaccination programmes encourages improvements in uptake levels. NICE guidance PH21: Reducing differences in the uptake of immunisations aims to increase immunisation uptake among those aged under 19 years from groups where uptake is low.

Figure 29. Chart showing immunisation uptake for selected childhood and adult vaccines in Hackney compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

In 2022/23, the percentage vaccine coverage of Dtap/IPV/Hib at 1 year old for Hackney residents was 67.8 (in 2021/22 it was 64.0). This was worse than 91.8 for England. The rank of Hackney was 149th highest (out of 150 UTLAs/UAs).

In 2022/23, the percentage vaccine coverage of one dose of MMR at 2 years old for Hackney residents was 68.1 (in 2021/22 it was 65.4). This was worse than 89.3 for England. The rank of Hackney was 149th highest (out of 150 UTLAs/UAs).

Table 2. Coverage of selected immunisation by year (%), Hackney (- indicates no data available)

Indicator 2012/13 2013/14 2014/15 2015/16 2016/17 2017/18 2018/19 2019/20 2020/21 2021/22 2022/23
Dtap/IPV/Hib (1yrs) 86.4 86.7 85.6 83.0 75.6 75.6 73.2 73.6 67.8 64.0 67.8
Rotavirus (1 yr) - - - - 68.1 70.1 68.1 70.9 63.9 61.7 62.8
Hepatitis B (1yr) - - 78.6 100.0 88.0 - 58.8 50.0 87.5 93.8 93.3
PCV booster 86.4 89.1 88.9 88.0 79.6 76.4 74.0 73.9 70.5 64.3 67.7
Dtap/IPV/Hib (2yrs) 91.4 91.7 92.2 89.8 86.4 83.7 81.6 80.1 77.8 70.6 70.8
Hib/Men C booster (2yrs) 86.8 87.9 90.8 84.2 77.9 72.9 71.2 72.2 68.0 61.6 63.4
MMR for one dose (2yrs) 85.7 88.4 88.2 84.1 78.3 75.0 74.3 77.1 70.7 65.4 68.1
Hepatitis B (2yr) - - 70.0 95.7 83.3 - 61.9 43.8 50.0 80.0 100.0
MMR for one dose (5yrs) 91.7 92.2 93.7 91.4 90.4 91.8 89.2 89.0 87.5 83.5 81.2
MMR for two doses (5yrs) 79.2 83.2 89.4 82.2 75.2 69.7 65.7 68.7 63.7 58.9 56.3
2 doses HPV (females 13-14yrs) - - - 64.1 78.6 72.2 69.8 67.4 61.1 60.0 -
Flu (aged 65+) 73.0 71.0 70.4 66.1 65.1 66.6 63.8 64.4 66.9 63.6 61.4
Flu (at risk individuals) 56.3 56.2 52.4 44.4 45.6 44.6 41.0 40.9 42.2 37.0 36.3
PPV 65.2 64.3 64.6 64.7 64.8 62.3 60.8 59.8 62.2 - -
Shingles (71 yrs old) - - - - - - - 26.1 27.0 27.4 -

Figure 30. Immunisation uptake (%) for selected childhood and adult vaccines by year in Hackney compared to London region and England: 2010/11 to 2022/23

Respiratory infection

This section has information on Tuberculosis (TB) and Legionella. Information on influenza infection is not yet available on the Health Protection Profiles although some immunisation data is presented.

Figure 31. Chart showing respiratory information in Hackney compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Tuberculosis

Tuberculosis (TB) is an infectious disease that usually affects the lungs, although it can affect almost any part of the body. People at higher risk of TB include those who have medical conditions that weaken the immune system (including HIV), homeless persons, people who inject drugs, those who have lived in areas of the world with high rates of TB, and close contacts of a person who has infectious TB. More local information on TB can be found on the online TB profiles and UKHSA Region reports.

In the 3 years from 2019 - 21, the number of Hackney residents who were diagnosed with TB was 123 (the number in 2018 - 20 was 127). The 3 year mean TB diagnoses rate per 100,000 residents was 15.0, worse than 7.8 per 100,000 in England. The rank of Hackney was 26th highest (out of 150 UTLAs/UAs). Since 2018 - 20, the decrease in Hackney was 1%; in the 5 years since 2014 - 16, the decrease was 41%.

Figure 32. 3 year mean rates per 100,000 population of TB in 16 similar UTLAs/UAs and the London region, compared to England: 2019 - 21

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 33. 3 year mean TB diagnoses per 100,000 population in Hackney, the London region and England

The percentage of TB cases in Hackney in 2021 who had been offered a test for HIV was 98.0%, similar to 98.4% in England. The percentage of TB cases in Hackney in 2021 starting treatment within 4 months was 69.2%, similar to 68.4% in England.

Figure 34. TB indicators in Hackney compared to London region and England: 2010/11 to 2022/23

Legionella

Legionnaires’ disease is caused by Legionella bacteria. It is an important health protection issue as infection can result in pneumonia and has a high mortality rate, especially in the elderly and immunosuppressed individuals. The organism is ubiquitous and can colonise poorly designed and/or poorly maintained wet cooling systems, which have the potential to cause large outbreaks.

In 2020, the number of Hackney residents who were diagnosed with legionella was 0 (the number in 2019 was 1). The legionella diagnoses rate per 100,000 residents was 0.0 in 2020, similar to 0.6 per 100,000 in England. The rank of Hackney was 142nd highest (out of 150 UTLAs/UAs).

Figure 35. Rates per 100,000 population of legionella in 16 similar UTLAs/UAs and the London region, compared to England: 2020

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 36. Legionella diagnoses per 100,000 population in Hackney, the London region and England

Hepatitis

Hepatitis refers to inflammation of the liver, which can be due to infectious and non-infectious causes. In this section, information is presented on the viral infections hepatitis B and C. Information on hepatitis A is not currently available on the Health Protection Profiles. For more local information on hepatitis please access UKHSA Region hepatitis B and hepatitis C reports.

Figure 37. Chart showing hepatitis information in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Hepatitis B

Hepatitis B is vaccine preventable and an important health protection issue that can cause serious disease. Variation in the incidence rate may reflect outbreaks, differences in the number of people in risk groups (such as migrants from countries with a high prevalence of hepatitis B, gay, bisexual and other men who have sex with men (GBMSM), people who inject drugs), in addition to variation in uptake of vaccination of risk groups. High rates of acute hepatitis B should prompt a review of cases to determine underlying reasons and to identify appropriate interventions.

In 2021, the number of Hackney residents who were newly diagnosed with acute hepatitis B was 2 (the number in 2020 was 0). The rate of new diagnoses per 100,000 residents was 0.8, similar to the rate of 0.3 per 100,000 in England. The rank of Hackney for the rate of new acute hepatitis B diagnoses was 18th highest (out of 150 UTLAs/UAs).

Figure 38. Rates per 100,000 population of acute hepatitis B in 16 similar UTLAs/UAs and the London region, compared to England: 2021

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 39. Acute hepatitis B diagnoses per 100,000 population in Hackney, the London region and England

In 2017 - 19 the under 75 mortality rate from hepatitis B related end-stage liver disease/hepatocellular carcinoma per 100,000 residents was 0.4, similar to the rate of 0.1 per 100,000 in England. The rank of Hackney was 14th highest (out of 149 UTLAs/UAs).

Hepatitis C

Hepatitis C is an important health protection issue. The infection increases people's risk of developing serious long term disease. About a third of people infected with hepatitis C virus will eventually develop liver cirrhosis accompanied with an increased risk of developing liver cancer. Hepatitis C is difficult to diagnose. Variation in detection rates may reflect differences in local testing activity as well as differences in the number of people in risk groups (such as people who inject drugs).

In 2017 the rate of hepatitis C detection in per 100,000 residents was 41.2, higher than the rate of 18.4 per 100,000 in England. The rank of Hackney for the rate of hepatitis C detections was 14th highest (out of 146 UTLAs/UAs).

Figure 40. Rates per 100,000 population of hepatitis C detection in 16 similar UTLAs/UAs and the London region, compared to England: 2017

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

In 2017 - 19 the under 75 mortality rate from hepatitis C related end-stage liver disease/hepatocellular carcinoma per 100,000 residents was 0.2, similar to the rate of 0.5 per 100,000 in England. The rank of Hackney was 115th highest (out of 149 UTLAs/UAs).

STIs and HIV

Sexually transmitted infections

As STIs are often asymptomatic, frequent screening of risk groups is important. Early detection and treatment can reduce important long-term consequences, such as infertility and ectopic pregnancy. While vaccination is a measure that can be used to control genital warts, hepatitis A and hepatitis B, control of other STIs relies on consistent and correct condom use, behaviour change to decrease overlapping and multiple partners, ensuring prompt access to testing and treatment, and ensuring partners of cases are notified and tested.

The burden of STIs in England continues to be greatest in young people, gay, bisexual and other men who have sex with men (GBMSM) and black ethnic minorities. Of all age-groups, the highest STI diagnosis rates in England are in young people aged 15-24 years. High levels of gonorrhoea transmission are of particular concern due to the emergence of extensively drug resistant gonorrhoea (XDR-NG) in England.

For more information on local sexual health access the sexual and reproductive health profiles which include downloadable summary profiles, and UKHSA Region reports.

It should be noted that if high rates of gonorrhoea and syphilis are observed in a population, this reflects high levels of risky sexual behaviour. When interpreting trends, please note that recent decreases in genital warts diagnoses may be due to the protective effect of HPV vaccination, and are particularly evident in the younger age groups, offered the vaccine since the national programme began. An increase in genital herpes diagnoses may be due to the use of more sensitive tests.

Figure 41. Chart showing key STI indicators in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Burden and trend of new STIs

Overall, the number of new sexually transmitted infections (STIs) diagnosed among residents of Hackney in 2022 was 7,531. The rate was 2,897 per 100,000 residents, higher than the rate of 694 per 100,000 in England.

Hackney ranked 3rd highest out of 147 UTLAs/UAs for new STI diagnoses (excluding chlamydia among young people aged 15-24 years) in 2022, with a rate of 2,452 per 100,000 residents, worse than the rate of 496 per 100,000 for England.

Since 2021, the increase in the rate of new STI diagnoses (excluding chlamydia among young people aged 15-24 years) in Hackney was 34%, and since 2017, the increase was 14%.

Table 3. Rates per 100,000 population of new STIs in Hackney and England: 2021-2022

Diagnoses 2021 2022 % change 2021 to 2022* Rank among 16 similar UTLAs/UAs Rank within England: 2022 Value for England: 2022
New STIs 2,165.8 2,897.0 33.8% 3 3 694.2
New STIs (exc chlamydia aged <25)1 1,826.5 2,452.3 34.3% 3 3 495.8
Chlamydia 973.2 1,384.1 42.2% 2 2 352.4
Gonorrhoea 585.9 818.2 39.7% 3 4 146.1
Syphilis 60.0 63.9 6.4% 6 8 15.4
Genital warts 134.3 131.6 -2.0% 4 4 46.1
Genital herpes 91.2 122.3 34.2% 4 4 44.1
Mycoplasma genitalium 31.6 31.6 0.0% 11 21 12.8
Trichomoniasis 89.0 99.0 11.3% 1 2 13.1
As a response to the COVID-19 pandemic, since March 2020 the Government implemented national and regional lockdowns and social and physical distancing measures. These measures affected sexual behaviour and health service provision, which is reflected in sexual and reproductive health indicator data. Interpreting data from 2020 should consider these factors, especially when comparing with data from pre-pandemic years.
* Percent change not provided where the value in 2021 was 0.
These are Hackney and its 15 statistical nearest neighbours, excluding those where values were suppressed due to small numbers. First rank has the highest value. Nearest neighbours are derived from CIPFA’s Nearest Neighbours Model.
Out of 149 UTLAs/UAs in England, excluding those where values were suppressed due to small numbers. City of London and Isles of Scilly are always excluded. First rank has the highest value. Where the value was 0, ranks are based on order of local authority names.
1 Population is restricted to those aged 15-64 years

Table 4. Number of new STIs by year, Hackney

Diagnoses 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
New STIs 6,258 6,668 7,001 6,820 6,947 7,278 8,362 9,430 5,391 5,630 7,531
New STIs (exc chlamydia aged <25)1 5,099 5,252 5,622 5,640 5,563 5,916 6,561 7,683 4,441 4,748 6,375
Chlamydia 2,337 2,707 2,870 2,545 2,865 3,062 3,922 4,398 2,414 2,530 3,598
Gonorrhoea 777 902 1,050 1,130 1,010 1,301 1,543 2,003 1,389 1,523 2,127
Syphilis 83 94 111 132 152 156 172 187 172 156 166
Genital warts 749 716 728 758 684 662 616 603 282 349 342
Genital herpes 507 550 550 555 536 465 459 522 196 237 318
Mycoplasma genitalium - - - - - - - 135 83 85 85
Trichomoniasis 247 253 238 202 333 425 472 498 202 239 266
1 Population is restricted to those aged 15-64 years
Figure 42. Rates per 100,000 population of new STIs excluding chlamydia in <25 years in 16 similar UTLAs/UAs and the London region, compared to England: 2022

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 43. Rates per 100,000 population by diagnosis by year in Hackney compared to rates in the London region and England: 2012 to 2022

Please note the charts have different y axis scales.

Gonorrhoea

In 2022, the number of Hackney residents who were diagnosed with gonorrhoea was 2,127 (the number in 2021 was 1,523). The gonorrhoea diagnoses rate per 100,000 residents was 818 in 2022, worse than 146 per 100,000 in England. The rank of Hackney was 4th highest (out of 147 UTLAs/UAs). Since 2021, the increase in the rate of gonorrhoea in Hackney was 40% and in the 5 years since 2017, the increase was 74%.

Figure 44. Rates per 100,000 population of gonorrhoea in 16 similar UTLAs/UAs and the London region, compared to England: 2022

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Syphilis

In 2022, the number of Hackney residents who were diagnosed with syphilis was 166 (the number in 2021 was 156). The syphilis diagnoses rate per 100,000 residents was 63.9 in 2022, worse than 15.4 per 100,000 in England. The rank of Hackney was 8th highest (out of 147 UTLAs/UAs). Since 2021, the increase in the rate of syphilis in Hackney was 6%, and in the 5 years since 2017, the increase was 13%.

Figure 45. Rates per 100,000 population of syphilis in 16 similar UTLAs/UAs and the London region, compared to England: 2022.

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Chlamydia detection

Since chlamydia is most often asymptomatic, a high detection rate reflects success at identifying infections that, if left untreated, may lead to serious reproductive health consequences. The detection rate is not a measure of prevalence. UKHSA recommends that local areas work towards the revised Public Health Outcomes Framework benchmark detection rate indicator of 3,250 per 100,000 resident females aged 15-24 year. Areas already achieving this rate should aim to maintain or increase it. High detection levels can only be achieved through the ongoing commissioning of high-volume, good quality screening services across primary care and sexual health services.

The chlamydia detection rate in females aged 15-24 in 2022 in Hackney was 3,833 per 100,000 population, higher than the 3,250 target. 34.3% of 15-24 year olds were tested for chlamydia, compared to 15.2% nationally. The detection rate per 100,000 and its rank in London region and England are shown in Table 5.

Table 5. Chlamydia detection rate per 100,000 population and percentage screened in 15-24 year olds in Hackney, the London region and England: 2022

2021 2022 % change 2021 to 2022* Rank among 16 similar UTLAs/UAs Rank within England: 2022 Value for England: 2022
Detection rate
Total 2,682.5 3,520.6 31.2% 1 2 1,680.1
Women 3,238.3 3,833.0 18.4% 1 5 2,110.0
Men 1,982.1 3,125.6 57.7% 1 1 1,111.6
Percentage screened
People aged 15-24 30.2 34.3 13.6% 2 2 15.2
As a response to the COVID-19 pandemic, since March 2020 the Government implemented national and regional lockdowns and social and physical distancing measures. These measures affected sexual behaviour and health service provision, which is reflected in sexual and reproductive health indicator data. Interpreting data from 2020 should consider these factors, especially when comparing with data from pre-pandemic years.
* Percent change proportional to the value in 2021, not a change in percentage points. Percent change not provided where the value in 2021 was 0.
These are Hackney and its 15 statistical nearest neighbours, excluding those where values were suppressed due to small numbers. First rank has the highest value. Nearest neighbours are derived from CIPFA’s Nearest Neighbours Model.
Out of 149 UTLAs/UAs in England, excluding those where values were suppressed due to small numbers. City of London and Isles of Scilly are always excluded. First rank has the highest value. Where the value was 0, ranks are based on order of local authority names.
Figure 46. Chlamydia detection rate per 100,000 females aged 15-24 in 16 similar UTLAs/UAs and the London region, compared to target: 2022

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

In the five years from 2017 to 2022, there was a 29% decrease in the chlamydia detection rate among females aged 15-24 in Hackney. From 2021, the increase was 18%.

Figure 47. Chlamydia detection rate per 100,000 population in females aged 15-24 by year in Hackney, the London region and England

STI testing in sexual health services

In 2022 the rate of STI testing (excluding chlamydia in under 25 year olds) in sexual health services in Hackney was 17,223 per 100,000 aged 15 to 64 years, a 20% increase compared to 2021. This is better than the rate of 3,856 per 100,000 in England in 2022. The positivity rate in Hackney was 9.3% in 2022, higher than 7.6% in England.

Figure 48. STI testing rate and positivity rate (excluding chlamydia in under 25 year olds) per 100,000 population aged 15-64 years by year in Hackney, the London region and England: 2012 to 2022

Other infections transmitted sexually

Other infections can be spread through sexual intercourse in addition to other routes, e.g. hepatitis B, hepatitis C and some infections are spread faecal-orally during sexual activity - termed sexually transmissible enteric infections (STEI) e.g. hepatitis A and Shigella.

HIV

Free and effective antiretroviral therapy (ART) in the UK has transformed HIV from a fatal infection into a chronic but manageable condition. People living with HIV in the UK can now expect to have a near normal life expectancy if diagnosed promptly and they adhere to treatment. The population groups who have been most at risk of HIV in the UK have been GBMSM and black African people. With progressive strengthening of combination prevention (including condom use, expanded HIV testing, prompt antiretroviral therapy and availability of pre-exposure prophylaxis), HIV transmission, AIDS and HIV-related deaths could be eliminated in the UK. For more local information on HIV please access the UKHSA Region Reports.

Figure 49. Chart showing key HIV indicators in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

People living with diagnosed HIV

In 2022, the number of Hackney residents aged 15-59 years who were seen at HIV services (the prevalence of diagnosed HIV) was 1,245. The diagnosed prevalence per 1,000 residents aged 15-59 years was 6.8, worse than 2.3 per 1,000 in England). The rank of Hackney was 11th highest (out of 147 UTLAs/UAs). Since 2021, the increase in Hackney was 1%; in the 5 years since 2017, the decrease was 13%.

Figure 50. Diagnosed HIV prevalence per 1,000 population aged 15-59 years by year in Hackney compared to rates in the London region and England: 2011 to 2022.

Figure 51. Diagnosed HIV prevalence per 1,000 population aged 15-59 years in 16 similar UTLAs/UAs and the London region, compared to England: 2022

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

The percentage of people in Hackney newly diagnosed with HIV from 2020 - 22 who started antiretroviral therapy (ART) promptly (within 91 days of their diagnosis) was 87.7%, similar to 85.4% in England.

The percentage of adults in Hackney accessing HIV care in 2022 who were virally suppressed (undetectable viral load) was 96.8%, worse than 97.7% in England.

New HIV diagnoses

In 2022, the number of Hackney residents aged 15 years and older who were newly diagnosed with HIV was 71. The rate of new diagnoses per 100,000 residents was 26.4, worse than the rate of 6.7 per 100,000 in England. This represented a 77% increase since 2021 and a 7% decrease in the 5 years since 2017. The rank of Hackney for the rate of new HIV diagnoses was 4th highest (out of 147 UTLAs/UAs). In 2022, the number of Hackney residents aged 15 years and older who were newly diagnosed with HIV and their first diagnosis was in the UK was 40.

Figure 52. Rate of new HIV diagnoses per 100,000 population among people aged 15 years or above by year in Hackney compared to rates in the London region and England: 2011 to 2022.

Figure 53. New HIV diagnoses rate per 100,000 population aged 15 years and above in 16 similar UTLAs/UAs and the London region, compared to England: 2022

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Late HIV diagnosis

Late diagnosis is the most important predictor of HIV-related morbidity and short-term mortality. It is a critical component of the PHOF, and monitoring is essential to evaluate the success of local HIV testing efforts. Diagnoses made at a late stage of infection are defined as having a CD4 cell count less than 350 cells per mm3 within three months of diagnosis.

In Hackney, the percentage of HIV diagnoses in people first diagnosed with HIV in the UK made at a late stage of infection in 2020 - 22 was 36.2% (95% CI 26.5 to 46.7), similar to 43.3% (95% CI 42.0 to 44.6) in England.

Figure 54. Percentage of late HIV diagnoses in 16 similar UTLAs/UAs and London region, compared to England: 2020 - 22

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 55. Percentage of late HIV diagnoses in Hackney compared to the London region and England: 2009-11 to 2020-22

For Hackney residents, the percentage of HIV diagnoses made at a late stage of infection for different risk groups in 2020 - 22 was as follows: GBMSM - 21.9% (95% CI 9.3 to 40.0), similar to 34.2% (95% CI 32.1 to 36.4) in England; heterosexual men - 50.0% (95% CI 26.0 to 74.0), similar to 58.9% (95% CI 55.8 to 62.0) in England; heterosexual women - 54.5% (95% CI 32.2 to 75.6), similar to 49.9% (95% CI 47.0 to 52.7) in England.

HIV testing

In 2022, the percentage of eligible SHS attendees in Hackney who received an HIV test was 58.3%, better than 48.2% for England. This represented a 22% increase since 2021, and a 17% decrease since 2017. For 2022, the percentage of MSM in Hackney who had tested more than once in the previous year was 51.5%, better than 47.3% in England.

Table 6. Coverage of HIV testing among eligible patients at specialist SHSs Hackney, London region and England: 2022

2021 2022 % change 2021 to 2022* Rank among 16 similar UTLAs/UAs Rank within England: 2022 Value for England: 2022
Total 47.7 58.3 22.2% 8 37 48.2
Women 32.9 45.5 38.2% 8 54 38.5
Men 69.1 71.3 3.3% 8 45 65.1
GBMSM 79.0 75.5 -4.4% 9 81 74.1
As a response to the COVID-19 pandemic, since March 2020 the Government implemented national and regional lockdowns and social and physical distancing measures. These measures affected sexual behaviour and health service provision, which is reflected in sexual and reproductive health indicator data. Interpreting data from 2020 should consider these factors, especially when comparing with data from pre-pandemic years.
* Percent change proportional to the value in 2021, not a change in percentage points. Percent change not provided where the value in 2021 was 0.
These are Hackney and its 15 statistical nearest neighbours, excluding those where values were suppressed due to small numbers. First rank has the highest value. Nearest neighbours are derived from CIPFA’s Nearest Neighbours Model.
Out of 149 UTLAs/UAs in England, excluding those where values were suppressed due to small numbers. City of London and Isles of Scilly are always excluded. First rank has the highest value. Where the value was 0, ranks are based on order of local authority names.
When calculating these rates, eligibility for HIV testing is determined by reviewing previous HIV diagnosis and testing history for each patient. Those who are known to be HIV positive, based on their GUMCADv2 history, are not considered eligible for testing. Those who have been tested already are not considered eligible to be tested again until six weeks have passed (i.e. eligibility for testing occurs only once every six weeks).

Group A streptococcal infection

Streptococcus pyogenes or group A streptococci (GAS) bacteria is of public health importance because it is highly contagious and occasionally the GAS can cause serious and life threatening disease.

Figure 56. Chart showing group A streptococcal information in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Scarlet fever is caused by GAS. Those most at risk of infection are children between the ages of two and eight years. Variation in notification rates may reflect differences in the underlying population or variation in the level of reporting of scarlet fever by clinicians.

In 2021, the number of Hackney residents under 10 years who were notified as having scarlet fever was 0 (the number in 2020 was 14). The scarlet fever notification rate per 100,000 residents aged under 10 years was 0.0 in 2021, better than 32.4 per 100,000 in England. The rank of Hackney was 142nd highest (out of 150 UTLAs/UAs).

Figure 57. Scarlet fever notification rates per 100,000 population in 16 similar UTLAs/UAs and the London region, compared to England: 2021

Similar refers to statistical nearest neighbours, derived from CIPFA’s Nearest Neighbours Model

Figure 58. Rate of scarlet fever notifications per 100,000 population aged 0-9 years by year in Hackney compared to rates in the London region and England: 2012 to 2021.

Health care associated infection

The only information presented here relates to antibiotic prescribing. For more information on anti-microbial resistance (AMR) in hospital and other settings please access the AMR local indicators site.

Figure 59. Chart showing HCAI information in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Antibiotic prescribing in primary care

Reducing antibiotic consumption is a well-recognised target in anti-microbial policies and can be used as an overall metric for benchmarking across local authorities. In order to fully appreciate antimicrobial prescribing, it is necessary to take into consideration demographic characteristics of the population as it may influence levels of prescribing and therefore this data is adjusted for both age and sex.

In 2022, the number of antibiotic items prescribed in primary care in Hackney was 97,928, a 13% increase since 2021 (n = 86827). The adjusted primary care prescribing rate was 0.6 in 2022, better than 0.9 per 100,000 in England. The rank of Hackney for this was 142nd highest (out of 150 UTLAs/UAs).

Figure 60. Adjusted antibiotic prescribing rate in primary care by the NHS in Hackney, the London region and England

Non-infectious environmental hazards

The only information presented here is mortality attributable to particulate air pollution.

Figure 61. Chart showing non-infectious environmental hazards information in Hackney local authority compared to the rest of England

The local result for each indicator is shown as a circle, against the range of results for England shown as a grey bar. The line at the centre of the chart shows the England average, the diamond shows the average for the London region.

Compared to England:

  • Better Better
  • Similar Similar
  • Worse Worse
  • or
  • Lower Lower
  • Similar Similar
  • Higher Higher
  • or
  • Not compared Not compared

Key for spine bars

Air pollution

Poor air quality is a significant public health issue. The burden of air pollution in the UK in 2013 was estimated to be equivalent to approximately 28,000-36,000 deaths at typical ages and an associated loss of population life of 328,000-416,000 life years lost 1. This indicator displays the fraction of mortality attributable to particular air pollution and will enable local authorities to prioritise action on air quality in their local area to help reduce the health burden from air pollution.

The fraction of mortality attributable to particulate air pollution was 7.0% in 2021, and not compared to 5.5% in England. The rank of Hackney for this was 4th highest (out of 150 UTLAs/UAs).

Figure 62. Fraction of mortality attributable to particulate air pollution in Hackney, the London region and England

Data sources

  • Acute hepatitis B incidence rate/100,000. Data source: UKHSA surveillance Acute Hepatitis B dataset, compiled from laboratory and Health Protection Team reports

  • Adjusted antibiotic prescribing in primary care by the NHS. Data source: Data is sourced from ePACT2 from NHS Digital

  • All new STI diagnoses rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Campylobacter incidence rate/100,000. Data source: UKHSA Second Generation Surveillance System - SGSS - (Laboratory Surveillance)

  • Children in care immunisations. Data source: Department for Education (DfE)

  • Chlamydia detection rate per 100,000 aged 15 to 24. Data source: UK Health Security Agency (UKHSA)

  • Chlamydia detection rate per 100,000 aged 15 to 24. Data source: UK Health Security Agency (UKHSA)

  • Chlamydia diagnostic rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Chlamydia diagnostic rate per 100,000 aged 25 years and older. Data source: UK Health Security Agency (UKHSA)

  • Chlamydia proportion aged 15 to 24 screened. Data source: UK Health Security Agency (UKHSA)

  • Cryptosporidium incidence rate/100,000. Data source: UKHSA Second Generation Surveillance System - SGSS - (Laboratory Surveillance)

  • Fraction of mortality attributable to particulate air pollution (new method). Data source: Background annual average PM2.5 concentrations for the year of interest are modelled on a 1km x 1km grid using an air dispersion model, and calibrated using measured concentrations taken from background sites in Defra’s Automatic Urban and Rural Network (https://uk-air.defra.gov.uk/interactive-map). By approximating LA boundaries to the 1km by 1km grid, and using census population data, population weighted background PM2.5 concentrations for each lower tier LA are calculated. This work is completed under contract to Defra, as a small extension of its obligations under the Ambient Air Quality Directive (2008/50/EC). Concentrations of total PM2.5 are used for estimating the mortality burden attributable to particulate air pollution (COMEAP, 2022).

  • Fraction of mortality attributable to particulate air pollution (old method). Data source: Background annual average PM2.5 concentrations for the year of interest are modelled on a 1km x 1km grid using an air dispersion model, and calibrated using measured concentrations taken from background sites in Defra’s Automatic Urban and Rural Network (http://uk-air.defra.gov.uk/interactive-map.) Data on primary emissions from different sources and a combination of measurement data for secondary inorganic aerosol and models for sources not included in the emission inventory (including re-suspension of dusts) are used to estimate the anthropogenic (human-made) component of these concentrations. By approximating LA boundaries to the 1km by 1km grid, and using census population data, population weighted background PM2.5 concentrations for each lower tier LA are calculated. This work is completed under contract to Defra, as a small extension of its obligations under the Ambient Air Quality Directive (2008/50/EC). Concentrations of anthropogenic, rather than total, PM2.5 are used as the basis for this indicator, as burden estimates based on total PM2.5 might give a misleading impression of the scale of the potential influence of policy interventions (COMEAP, 2012).

  • Genital herpes diagnosis rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Genital warts diagnostic rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Giardia incidence rate/100,000. Data source: UKHSA Second Generation Surveillance System - SGSS - (Laboratory Surveillance)

  • Gonorrhoea diagnostic rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • HIV diagnosed prevalence rate per 1,000 aged 15 to 59. Data source: UK Health Security Agency (UKHSA)

  • HIV late diagnosis in gay, bisexual and other men who have sex with men first diagnosed with HIV in the UK. Data source: UK Health Security Agency (UKHSA)

  • HIV late diagnosis in heterosexual and bisexual women first diagnosed with HIV in the UK. Data source: UK Health Security Agency (UKHSA)

  • HIV late diagnosis in heterosexual men first diagnosed with HIV in the UK. Data source: UK Health Security Agency (UKHSA)

  • HIV late diagnosis in people first diagnosed with HIV in the UK. Data source: UK Health Security Agency (UKHSA)

  • HIV testing coverage, gay, bisexual and other men who have sex with men. Data source: UK Health Security Agency (UKHSA)

  • HIV testing coverage, men. Data source: UK Health Security Agency (UKHSA)

  • HIV testing coverage, total. Data source: UK Health Security Agency (UKHSA)

  • HIV testing coverage, women. Data source: UK Health Security Agency (UKHSA)

  • Hepatitis C detection rate/100,000. Data source: SGSS data (Second Generation Surveillance System) - Laboratory reporting. UKHSA

  • Invasive Meningococcal Disease (IMD) confirmed cases rate/100,000. Data source: UKHSA Meningococcal Reference Unit (MRU)

  • Legionnaires’ disease confirmed incidence rate/100,000. Data source: National Enhanced Surveillance Scheme for Legionnaires’ disease in residents of England, UKHSA

  • Listeria 5-year incidence rate/100,000. Data source: National Enhanced Surveillance Scheme for Listeria for residents of England and Wales, UKHSA

  • Listeria incidence rate/100,000. Data source: National Enhanced Surveillance Scheme for Listeria for residents of England and Wales, UKHSA

  • Measles 5-year incidence rate/100,000. Data source: UKHSA Measles Enhanced Surveillance Programme.

  • Measles incidence rate/100,000. Data source: UKHSA Measles Enhanced Surveillance Programme.

  • Mumps 5-year incidence rate/100,000. Data source: UKHSA Mumps Enhanced Surveillance Programme

  • Mumps incidence rate/100,000. Data source: UKHSA Mumps Enhanced Surveillance Programme

  • Mycoplasma genitalium diagnostic rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • New HIV diagnoses among persons first diagnosed in the UK rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • New HIV diagnosis rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • New STI diagnoses (excluding chlamydia aged under 25) per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Non-typhoidal Salmonella incidence rate/100,000. Data source: UKHSA Second Generation Surveillance System - SGSS - (Laboratory Surveillance)

  • Persons entering drug misuse treatment - Percentage of eligible persons completing a course of hepatitis B vaccination. Data source: Public Health England, National Drug Treatment Monitoring System (NDTMS)

  • Persons in drug misuse treatment who inject drugs - Percentage of eligible persons who have received a hepatitis C test. Data source: Public Health England, (based on National Drug Treatment Monitoring System data)

  • Pertussis incidence rate/100,000. Data source: UKHSA pertussis enhanced surveillance programme

  • Population vaccination coverage - Hib / Men C booster (5 years old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by Public Health England (PHE). Available from NHS Digital

  • Population vaccination coverage - Shingles vaccination coverage (70 years old). Data source: Public Health England

  • Population vaccination coverage BCG: areas offering universal BCG only. Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA)

  • Population vaccination coverage: Rotavirus (Rota) (1 year). Data source: NHS Digital

  • Population vaccination coverage: Dtap IPV Hib (2 years old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA|). Available from NHS Digital

  • Population vaccination coverage: Dtap IPV Hib (1 year old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital

  • Population vaccination coverage: Flu (aged 65 and over). Data source: https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures

  • Population vaccination coverage: Flu (at risk individuals). Data source: https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures

  • Population vaccination coverage: Flu (primary school aged children). Data source: https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptake:-figures Influenza Immunisation Vaccine Uptake Monitoring Programme

  • Population vaccination coverage: HPV vaccination coverage for two doses (13 to 14 years old). Data source: UK Health Security Agency (UKHSA)

  • Population vaccination coverage: Hepatitis B (1 year old). Data source: Cover of vaccination evaluated rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital (former Health and Social Care Information Centre) and UKHSA.

  • Population vaccination coverage: Hepatitis B (2 years old). Data source: Cover of vaccination evaluated rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital (former Health and Social Care Information Centre)

  • Population vaccination coverage: Hib and MenC booster (2 years old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital

  • Population vaccination coverage: MMR for one dose (2 years old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital

  • Population vaccination coverage: MMR for one dose (5 years old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital

  • Population vaccination coverage: MMR for two doses (5 years old). Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital ”

  • Population vaccination coverage: Meningococcal ACWY conjugate vaccine (MenACWY) (14 to 15 years). Data source: UK Health Security Agency (UKHSA)

  • Population vaccination coverage: PCV booster. Data source: Cover of Vaccination Evaluated Rapidly (COVER) data collected by UK Health Security Agency (UKHSA). Available from NHS Digital

  • Population vaccination coverage: PPV. Data source: UK Health Security Agency (UKHSA)

  • Population vaccination coverage: Shingles vaccination coverage (71 years). Data source: UK Health Security Agency (UKHSA)

  • Prompt antiretroviral therapy (ART) initiation in people newly diagnosed with HIV. Data source: UK Health Security Agency (UKHSA)

  • Proportion of TB notifications offered an HIV test. Data source: National Tuberculosis Surveillance System (NTBS). UK Health Security Agency (UKHSA).

  • Proportion of culture confirmed TB notifications with drug susceptibility testing reported for the four first line agents. Data source: National Tuberculosis Surveillance system (NTBS). UK Health Security Agency (UKHSA).

  • Proportion of drug sensitive TB cases who were lost to follow up at last reported outcome. Data source: National Tuberculosis System (NTBS) and Office for National Statistics (ONS)

  • Proportion of drug sensitive TB notifications who had completed a full course of treatment by 12 months. Data source: National Tuberculosis Surveillance System (NTBS)

  • Proportion of drug sensitive TB notifications who had died at last reported outcome. Data source: National Tuberculosis Surveillance system (NTBS)

  • Proportion of pulmonary TB notifications starting treatment within four months of symptom onset. Data source: National Tuberculosis Surveillance system (NTBS). UK Health Security Agency (UKHSA).

  • Proportion of pulmonary TB notifications starting treatment within two months of symptom onset. Data source: National Tuberculosis Surveillance system (NTBS). UK Health Security Agency (UKHSA).

  • Proportion of pulmonary TB notifications that were culture confirmed. Data source: National Tuberculosis Surveillance system (NTBS). UK Health Security Agency (UKHSA).

  • Repeat HIV testing in gay, bisexual and other men who have sex with men. Data source: UK Health Security Agency (UKHSA)

  • STEC (Shiga toxin-producing Escherichia coli) serogroup O157 5-year incidence rate/100,000. Data source: National Enhanced Shiga toxin producing Escherichia coli Surveillance System (NESSSy) for residents of England, UKHSA

  • STEC (Shiga toxin-producing Escherichia coli) serogroup O157 incidence rate/100,000. Data source: National Enhanced Shiga toxin-producing Escherichia coli Surveillance System (NESSSy) for residents of England, UKHSA

  • STI testing positivity (excluding chlamydia aged under 25). Data source: UK Health Security Agency (UKHSA)

  • STI testing rate (exclude chlamydia aged under 25) per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Scarlet fever notification rate/100,000 aged 0-9 yrs. Data source: NOIDS (Notifications of Infectious Disease Surveillance) https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids

  • Shigella incidence rate/100,000. Data source: UKHSA national Second Generation Surveillance System (SGSS) for laboratory surveillance of infectious disease

  • Syphilis diagnostic rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • TB incidence (three year average). Data source: National Tuberculosis Surveillance System (NTBS) and Office for National Statistics (ONS)

  • Trichomoniasis diagnostic rate per 100,000. Data source: UK Health Security Agency (UKHSA)

  • Typhoid & paratyphoid incidence rate/100,000. Data source: National Enhanced Surveillance Scheme for Typhoid and Paratyphoid in residents of England, UKHSA

  • Under 75 mortality rate from hepatitis B related end-stage liver disease/hepatocellular carcinoma. Data source: Office for Health Improvement and Disparities (OHID) (based on ONS source data)

  • Under 75 mortality rate from hepatitis C related end-stage liver disease/hepatocellular carcinoma. Data source: Office for Health Improvement and Disparities (OHID) (based on ONS source data)

  • Virological success in adults accessing HIV care. Data source: UK Health Security Agency (UKHSA)

Appendix 1: Counts of selected indicators

Table 7. Counts of selected disease indicators by calendar year, Hackney (- indicates that data is not available for this report)

Indicator 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Salmonella (non-typhoidal) - - - 37 43 59 - - - - -
Campylobacter - - - 165 145 70 - - - - -
Shigella - - - 84 64 62 - - - - -
STEC 8 3 7 3 1 2 5 - - - -
Listeria 2 2 1 2 3 0 0 - - - -
Giardia - - - 6 6 2 - - - - -
Cryptosporidium - - - 3 12 7 - - - - -
Typhoid/paratyphoid 1 5 6 6 6 3 3 4 - - -
Measles 43 62 2 2 23 6 65 96 0 0 -
Mumps 2 12 10 5 1 12 5 - - - -
Pertussis 22 19 16 32 53 31 37 51 7 0 -
Legionella - - - 0 0 0 1 1 0 - -
Acute Hepatitis B - - - - 11 1 6 4 0 2 -
Hepatitis C detection - - - - 127 102 - - - - -
New STIs 6,258 6,668 7,001 6,820 6,947 7,278 8,362 9,430 5,391 5,630 7,531
New STIs (exc chlamydia aged <25) 5,099 5,252 5,622 5,640 5,563 5,916 6,561 7,683 4,441 4,748 6,375
Chlamydia 2,337 2,707 2,870 2,545 2,865 3,062 3,922 4,398 2,414 2,530 3,598
Gonorrhoea 777 902 1,050 1,130 1,010 1,301 1,543 2,003 1,389 1,523 2,127
Syphilis 83 94 111 132 152 156 172 187 172 156 166
Genital warts 749 716 728 758 684 662 616 603 282 349 342
Genital herpes 507 550 550 555 536 465 459 522 196 237 318
People living with diagnosed HIV 1,373 1,455 1,488 1,530 1,500 1,500 1,458 1,424 1,309 1,234 1,245
New HIV diagnoses 130 139 110 116 78 81 68 57 34 40 71
Scarlet fever (0-9 years) 4 11 14 20 11 46 60 27 14 0 -

Table 8. Counts of selected disease indicators by July - June epidemic year, Hackney (- indicates that data is not available for this report)

Indicator Jul 2012 - Jun 2013 Jul 2013 - Jun 2014 Jul 2014 - Jun 2015 Jul 2015 - Jun 2016 Jul 2016 - Jun 2017 Jul 2017 - Jun 2018 Jul 2018 - Jun 2019 Jul 2019 - Jun 2020 Jul 2020 - Jun 2021
Invasive meningococcal disease 4 2 3 4 3 1 5 3 0

Acknowledgements

This report was developed by Paul Crook and Oliver McManus from the Field Service South East and London, Regions Directorate, Health Protection Operations Group, UKHSA (). They would like to thank the following:

References


  1. Associations of long-term average concentrations of nitrogen dioxide with mortality. A report by the Committee on the Medical Effects of Air Pollutants 2018 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/734799/COMEAP_NO2_Report.pdf↩︎